Home / Brand archive
15 reported ongoing
20 records in this archive. Latest source date Dec 18, 2025.
FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
Presence of particulate matter - Glass like particles.
Class IIReported ongoing
Distribution: U.S Nationwide
Presence of particulate matter - Glass like particles.
Class IIReported ongoing
Distribution: U.S Nationwide
Presence of particulate matter - Glass like particles.
Class IIReported ongoing
Distribution: U.S Nationwide
Subpotent Drug
Class IIIReported ongoing
Distribution: USA nationwide
Sub-Potent Drug: Subpotent assay results during stability testing.
Class IIReported completed
Distribution: Nationwide in the USA
Sub-Potent Drug: Subpotent assay results during stability testing.
Class IIIReported completed
Distribution: Nationwide in the USA
Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.
Class IIIReported ongoing
Distribution: FL and NY
Lack of Assurance of Sterility
Class IIReported ongoing
Distribution: Nationwide within the United States
Lack of Assurance of Sterility
Class IIReported ongoing
Distribution: Nationwide within the United States
Lack of Assurance of Sterility
Class IIReported ongoing
Distribution: Nationwide within the United States
Lack of Assurance of Sterility
Class IIReported ongoing
Distribution: Nationwide within the United States
Lack of Assurance of Sterility
Class IIReported ongoing
Distribution: Nationwide within the United States
Lack of Assurance of Sterility
Class IIReported ongoing
Distribution: Nationwide within the United States
Lack of Assurance of Sterility
Class IIReported ongoing
Distribution: US Nationwide
Lack of Assurance of Sterility
Class IIReported ongoing
Distribution: US Nationwide
Subpotent Drug
Class IIReported ongoing
Distribution: U.S. Nationwide
Out of specification for assay
Class IIIReported ongoing
Distribution: Nationwide within the United States
Subpotent: Failing Test Results for Epinephrine
Class IIIReported terminated
Distribution: Nationwide
Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.
Class IIIReported terminated
Distribution: Product was distributed to physician's offices nationwide.
Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.
Class IIIReported terminated
Distribution: Nationwide in the US
These examples come from this result page and are not a ranking of every recall reason.
This archive contains 20 records, including 15 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.